Literature DB >> 23450077

Holding Tight: Cell Junctions and Cancer Spread.

Alexander J Knights1, Alister P W Funnell, Merlin Crossley, Richard C M Pearson.   

Abstract

Cell junctions are sites of intercellular adhesion that maintain the integrity of epithelial tissue and regulate signalling between cells. These adhesive junctions are comprised of protein complexes that serve to establish an intercellular cytoskeletal network for anchoring cells, in addition to regulating cell polarity, molecular transport and communication. The expression of cell adhesion molecules is tightly controlled and their downregulation is essential for epithelial-mesenchymal transition (EMT), a process that facilitates the generation of morphologically and functionally diverse cell types during embryogenesis. The characteristics of EMT are a loss of cell adhesion and increased cellular mobility. Hence, in addition to its normal role in development, dysregulated EMT has been linked to cancer progression and metastasis, the process whereby primary tumors migrate to invasive secondary sites in the body. This paper will review the current understanding of cell junctions and their role in cancer, with reference to the abnormal regulation of junction protein genes. The potential use of cell junction molecules as diagnostic and prognostic markers will also be discussed, as well as possible therapies for adhesive dysregulation.

Entities:  

Keywords:  Cell junction; EMT; cell adhesion; epithelial-mesenchymal transition

Year:  2012        PMID: 23450077      PMCID: PMC3582402     

Source DB:  PubMed          Journal:  Trends Cancer Res        ISSN: 0973-1040


  51 in total

1.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail.

Authors:  Junichi Ikenouchi; Miho Matsuda; Mikio Furuse; Shoichiro Tsukita
Journal:  J Cell Sci       Date:  2003-03-26       Impact factor: 5.285

2.  Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

Authors:  Lindsay J Talbot; Syamal D Bhattacharya; Paul C Kuo
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

3.  Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.

Authors:  Meena Jaggi; Sonny L Johansson; John J Baker; Lynette M Smith; Anton Galich; K C Balaji
Journal:  Urol Oncol       Date:  2005 Nov-Dec       Impact factor: 3.498

Review 4.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 5.  Dynamics and functions of tight junctions.

Authors:  Emily Steed; Maria S Balda; Karl Matter
Journal:  Trends Cell Biol       Date:  2010-01-12       Impact factor: 20.808

6.  Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Authors:  Scott L Kominsky; Pedram Argani; Dorian Korz; Ella Evron; Venu Raman; Elizabeth Garrett; Alan Rein; Guido Sauter; Olli-P Kallioniemi; Saraswati Sukumar
Journal:  Oncogene       Date:  2003-04-03       Impact factor: 9.867

Review 7.  Regulation of adherens junctions by Rho GTPases and p120-catenin.

Authors:  Andre Menke; Klaudia Giehl
Journal:  Arch Biochem Biophys       Date:  2012-05-11       Impact factor: 4.013

8.  Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.

Authors:  Linlin Yang; Yuan Chen; Tiantian Cui; Thomas Knösel; Qing Zhang; Kai Frederik Albring; Otmar Huber; Iver Petersen
Journal:  Carcinogenesis       Date:  2012-07-12       Impact factor: 4.944

Review 9.  Tight junctions: molecular architecture and function.

Authors:  Saima Aijaz; Maria S Balda; Karl Matter
Journal:  Int Rev Cytol       Date:  2006

10.  Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.

Authors:  Anna-Mária Tokés; Janina Kulka; Sándor Paku; Agnes Szik; Csilla Páska; Pál Kaposi Novák; László Szilák; András Kiss; Krisztina Bögi; Zsuzsa Schaff
Journal:  Breast Cancer Res       Date:  2005-01-31       Impact factor: 6.466

View more
  43 in total

1.  β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model.

Authors:  Tung Bui; Babette Schade; Robert D Cardiff; Olulanu H Aina; Virginie Sanguin-Gendreau; William J Muller
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

2.  Impacts of Organomodified Nanoclays and Their Incinerated Byproducts on Bronchial Cell Monolayer Integrity.

Authors:  Todd A Stueckle; Andrew White; Alixandra Wagner; Rakesh K Gupta; Yon Rojanasakul; Cerasela Z Dinu
Journal:  Chem Res Toxicol       Date:  2019-11-19       Impact factor: 3.739

Review 3.  The effect of environmental chemicals on the tumor microenvironment.

Authors:  Stephanie C Casey; Monica Vaccari; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Mary Helen Barcellos-Hoff; Dustin G Brown; Marion Chapellier; Joseph Christopher; Colleen S Curran; Stefano Forte; Roslida A Hamid; Petr Heneberg; Daniel C Koch; P K Krishnakumar; Ezio Laconi; Veronique Maguer-Satta; Fabio Marongiu; Lorenzo Memeo; Chiara Mondello; Jayadev Raju; Jesse Roman; Rabindra Roy; Elizabeth P Ryan; Sandra Ryeom; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Laura Soucek; Louis Vermeulen; Jonathan R Whitfield; Jordan Woodrick; Annamaria Colacci; William H Bisson; Dean W Felsher
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 4.  Modulation of cytoskeletal dynamics by mammalian nucleoside diphosphate kinase (NDPK) proteins.

Authors:  Natasha T Snider; Peter J Altshuler; M Bishr Omary
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-20       Impact factor: 3.000

5.  Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.

Authors:  M Shriver; K M Stroka; M I Vitolo; S Martin; D L Huso; K Konstantopoulos; A Kontrogianni-Konstantopoulos
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

6.  Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis.

Authors:  Josephine Yates; Valentina Boeva
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

7.  Epigenetic effects of low-level sodium arsenite exposure on human liver HepaRG cells.

Authors:  Volodymyr P Tryndyak; Barbara Borowa-Mazgaj; Colleen R Steward; Frederick A Beland; Igor P Pogribny
Journal:  Arch Toxicol       Date:  2020-08-25       Impact factor: 5.153

Review 8.  The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.

Authors:  Tamsin Wesley; Stuart Berzins; George Kannourakis; Nuzhat Ahmed
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

9.  Analysis of salivary detection of P16INK4A and RASSF1A promoter gene methylation and its association with oral squamous cell carcinoma in a Colombian population.

Authors:  Leonor-Victoria González-Pérez; Diana-María Isaza-Guzmán; Eduin-Alonso Arango-Pérez; Sergio-Iván Tobón-Arroyave
Journal:  J Clin Exp Dent       Date:  2020-05-01

10.  A mouse model of human primitive neuroectodermal tumors resulting from microenvironmentally-driven malignant transformation of orthotopically transplanted radial glial cells.

Authors:  Sergey Malchenko; Simone Treiger Sredni; Hitoshi Hashimoto; Atsushi Kasai; Kazuki Nagayasu; Jianping Xie; Naira V Margaryan; Kaoru Seiriki; Rishi R Lulla; Richard E B Seftor; Lauren M Pachman; Herbert Y Meltzer; Mary J C Hendrix; Marcelo B Soares
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.